An exception to this general picture might be CD26 and IL1RAP that were very recently described as a CD34+/CD38− CML leukemia stem cell (LSC)-associated biomarker [15–17]. The gene discussed is CD38; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.